The Medicare Rights Center urges immediate action to address the long-standing problem of inaccurate MA provider directories. This misinformation derails thoughtful coverage choices and access to care. It also prevents proper oversight, as insufficient data may hide non-compliance with network adequacy and other requirements.
Immediate action is needed to transform the nation’s drug pricing system in ways that will lower prices, strengthen Medicare, and promote the well-being of those who rely on its coverage. H.R. 3 would significantly advance these goals, in part by authorizing Medicare to negotiate prices for certain drugs; imposing inflationary rebates; and restructuring Part D to cap beneficiary out-of-pocket costs at $2,000 per year, reduce the federal government’s liability, and better align pricing incentives.
Testimony of Frederic Riccardi, President Medicare Rights Center, on “The Future of Telehealth: How COVID-19 is Changing the Delivery of Virtual Care” for the United States House of Representatives Committee on Energy & Commerce Subcommittee on Health.
As policymakers consider the post-pandemic Medicare telehealth landscape, the Medicare Rights Center and the Center for Medicare Advocacy offer our shared perspective on next steps. In these joint principles, we urge a cautious, thoughtful, and evidence-based approach that centers the unique and evolving needs of people with Medicare.
Introduction Chairwoman Eshoo, Dr. Burgess, and members of the House Committee on Energy & Commerce, Subcommittee on Health: I am Fred Riccardi, president of the Medicare Rights Center (Medicare Rights). Medicare Rights is a national, non-profit organization that works to ensure access to affordable health care for older adults and […]
Chairman Grassley, Ranking Member Wyden, and distinguished Members of the Senate Committee on Finance, on behalf of the Medicare Rights Center (Medicare Rights), thank you for your bipartisan efforts to address the problem of high and rising prescription drug prices, and for the opportunity to share our perspective on this […]
The undersigned organizations of the Observation Stays Coalition have come together to address a surprise medical billing issue that affects Medicare patients in hospitals who are called observation status patients or outpatients, although the medically necessary care they need and receive is no different from the medically necessary care provided […]
The undersigned organizations of the Observation Stays Coalition have come together to address a surprise medical billing issue that affects Medicare patients in hospitals who are called observation status patients or outpatients, although the medically necessary care they need and receive is no different from the medically necessary care provided […]
The undersigned organizations of the Observation Stays Coalition have come together to address a surprise medical billing issue that affects Medicare patients in hospitals who are called observation status patients or outpatients, although the medically necessary care they need and receive is no different from the medically necessary care provided […]
Medicare Rights Center President Joe Baker testimony in support of the Centers for Medicare & Medicaid Services (CMS) proposal to test new ways to pay for prescription drugs covered under Medicare Part B, at a hearing held by the Subcommittee on Health of the U.S. House Committee on Energy and […]
